Holen Sie sich die Stockscreener-App
5.31
1.30%
-0.07
Handel nachbörslich:
5.31
Schlusskurs vom Vortag:
$5.38
Offen:
$5.12
24-Stunden-Volumen:
251.38K
Relative Volume:
0.76
Marktkapitalisierung:
$288.92M
Einnahmen:
$77.36M
Nettoeinkommen (Verlust:
$-38.43M
KGV:
-7.1679
EPS:
-0.7408
Netto-Cashflow:
$-29.92M
1W Leistung:
+25.83%
1M Leistung:
+53.91%
6M Leistung:
-24.57%
1J Leistung:
+72.40%
1-Tages-Spanne:
$5.12
$5.545
1-Wochen-Bereich:
$4.15
$5.6613
52-Wochen-Spanne:
$3.06
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
5.31 | 292.73M | 77.36M | -38.43M | -29.92M | -0.7408 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | Hochstufung | Lake Street | Hold → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-11-04 | Herabstufung | Lake Street | Buy → Hold |
| 2024-08-21 | Eingeleitet | Lake Street | Buy |
| 2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2022-10-04 | Eingeleitet | Needham | Hold |
| 2022-07-26 | Eingeleitet | Stifel | Hold |
| 2022-02-03 | Eingeleitet | William Blair | Outperform |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Sight Sciences (SGHT) Q1 Loss Of US$0.24 EPS Tests Margin Improvement Narrative - Sahm
Insiders At Sight Sciences Sold US$1.8m In Stock, Alluding To Potential Weakness - Moomoo
Sight Sciences(SGHT) Stock Options Chain | Quotes & News - Moomoo
Sight Sciences Financial Results for Q1 2026 Show Growth - VisionMonday.com
Sight Sciences Earnings Call Signals Disciplined Growth - TipRanks
Lake Street Initiates Sight Sciences(SGHT.US) With Buy Rating, Announces Target Price $12 - Moomoo
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2026 Earnings Call Transcript - Insider Monkey
Stifel Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Piper Sandler Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Sight Sciences signals $83M-$89M 2026 revenue outlook while targeting $6M-$8M dry eye sales - MSN
Sight Sciences (SGHT) Q1 2026 Earnings Transcript - AOL.com
Sight Sciences Q1 Earnings Call Highlights - Yahoo Finance
Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
Sight Sciences, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Sight Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance UK
SGHT: Double-digit revenue growth and raised guidance, with strong segment execution and patent win - TradingView
Earnings call transcript: Sight Sciences Q1 2026 revenue up, EPS misses - Investing.com
Sight Sciences Lifts 2026 Outlook After Strong Q1 - TipRanks
Sight Sciences (NASDAQ: SGHT) grows Q1 2026 sales and wins $55.4M judgment - Stock Titan
Sight Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Sight Sciences (NASDAQ: SGHT) boosts 2026 revenue outlook after strong Q1 - Stock Titan
BRIEF-Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million - TradingView
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance - ChartMill
Sight Sciences Q1 2026 Earnings Call Transcript - MarketBeat
Sight Sciences Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Sight Sciences Publishes Its 2025 Sustainability Report - VisionMonday.com
Sight Sciences to Present at Two Upcoming Investor Conferences - The Manila Times
Sight Sciences (SGHT) to Release Earnings on Wednesday - MarketBeat
Sight Sciences maps out two May investor conference appearances - Stock Titan
Sight Sciences Issues 2025 Sustainability Report on ESG Initiatives - VisionMonday.com
Sight Sciences awarded $55.4 million in patent case against Alcon By Investing.com - Investing.com Canada
Sight Sciences awarded $55.4 million in patent case against Alcon - Investing.com
Sight Sciences Wins Patent Judgment, Secures Ongoing Royalties - TipRanks
Sight Sciences (NASDAQ: SGHT) awarded $55.4M and 10% Hydrus royalty - Stock Titan
Sight Sciences Announces the Release of its Sustainability Report - The Manila Times
Sight Sciences (NASDAQ: SGHT) details 2026 meeting, director elections and auditor vote - Stock Titan
Sight Sciences will detail first-quarter results after market close May 6 - Stock Titan
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026 - marketscreener.com
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Sight Sciences wins $34M patent ruling against Alcon - MSN
KCK LTD. Significantly Reduces Stake in Sight Sciences Inc - GuruFocus
SGHT: Momentum builds for interventional glaucoma and dry eye, with innovation and adoption accelerating - TradingView
If You Invested $1,000 in Sight Sciences, Inc. (SGHT) - Stock Titan
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Sight Sciences CFO Rodberg sells $25,670 in shares By Investing.com - Investing.com India
Sight Sciences CLO Hayden sells shares worth $48,851 By Investing.com - Investing.com Canada
Sight Sciences CLO Hayden sells shares worth $48,851 - Investing.com
Sight Sciences CFO Rodberg sells $25,670 in shares - Investing.com
Sight Sciences (NASDAQ:SGHT) CFO James Rodberg Sells 7,231 Shares of Stock - MarketBeat
Sight Sciences (NASDAQ: SGHT) CFO sells 7,231 shares to cover RSU taxes - Stock Titan
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):